Cibus, Inc. Amends 8-K: Director Change and Compensation
Ticker: CBUS · Form: 8-K/A · Filed: Mar 27, 2025 · CIK: 1705843
| Field | Detail |
|---|---|
| Company | Cibus, Inc. (CBUS) |
| Form Type | 8-K/A |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, director-change, amendment
TL;DR
Cibus board shake-up: Director out, new one in, compensation details updated.
AI Summary
Cibus, Inc. filed an 8-K/A on March 27, 2025, to amend a previous filing concerning the departure of Director Dr. Jeffrey R. Binder and the election of Dr. Alan R. Kahn as a Class II Director, effective February 24, 2025. The filing also addresses compensatory arrangements for certain officers.
Why It Matters
This amendment clarifies changes in Cibus, Inc.'s board of directors and executive compensation, providing transparency to investors regarding corporate governance and potential impacts on company strategy.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous report and primarily concerns director changes and compensation, which are standard corporate governance events.
Key Players & Entities
- Cibus, Inc. (company) — Registrant
- Dr. Jeffrey R. Binder (person) — Departing Director
- Dr. Alan R. Kahn (person) — Elected Director
- February 24, 2025 (date) — Effective date of director change
- March 27, 2025 (date) — Filing date of 8-K/A
FAQ
Who is the new director elected to the Cibus, Inc. board?
Dr. Alan R. Kahn was elected as a Class II Director.
When was the director change effective?
The change was effective February 24, 2025.
What type of filing is this?
This is a Form 8-K/A, an amendment to a current report.
What is the primary purpose of this amendment?
The amendment concerns the departure of a director and the election of a new director, as well as compensatory arrangements for certain officers.
What was the former name of Cibus, Inc.?
The former name was Calyxt, Inc., with a name change date of May 4, 2017.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on March 27, 2025 by Dr. Jeffrey R. Binder regarding Cibus, Inc. (CBUS).